Percutaneous aortic valve replacement (TAVI) is a new treatment option for patients that are inoperable or present a high surgical risk. Some studies have shown that the stroke rate may be higher with TAVI than with medical treatment or surgical replacement. Embolic protection has been used successfully for the carotids, but there is not much<a href="https://solaci.org/en/2015/06/24/protavi-c-embolic-protection-during-tavi/" title="Read more" >...</a>
We evaluated 88 consecutive patients (at this phase) with severe aortic stenosis who received the second-generation device for transapical access. Survival at thirty days was 85.1% with a cardiovascular death rate of 4.8%. No strokes were observed during this period. Average gradient reduction was highly significant, (40.4 to 8.1 mmHg, p <0.001), as well as<a href="https://solaci.org/en/2015/06/24/jupiter-transapical-tavi-device/" title="Read more" >...</a>
Recentemente uma revisão e metanálise sobre obstrução coronária após o implante de TAVI foi publicada na revista JAAC. Este artigo foi motivo de uma aula no TCT 2013 ministrada pelo Dr. Henrique Ribeiro (autor principal deste estudo). Segue abaixo o resumo do estudo e a entrevista com o dr. Henrique: Obstrução coronária pós TAVI Fundamentos<a href="https://solaci.org/en/2015/06/24/exclusive-interview-with-dr-henrique-ribeiro-on-his-article-coronary-obstruction-after-tavi/" title="Read more" >...</a>
The Latin American Society of Interventional Cardiology successfully relaunched its SOLidario program, practicing the implantation of an aortic valve catheter (TAVI) in the Instituto de Angiografía de Occidente at Cali. It was during the XXIV SOLACI Conference edition held on October 30 and 31 in Colombia. SOLACI understands the need to develop a social<a href="https://solaci.org/en/2015/06/02/solaci-relaunches-its-solidario-program-in-colombia/" title="Read more" >...</a>
A catheterization is a procedure used to examine the condition of arteries in a specific organ of the body, for example, the arteries of the heart. To visualize vessels, an iodinated contrast dye is injected directly into the artery, which is reached from the peripheral access sites (a.k.a. thegroin, femoral access, traditionally preferred; the wrist,<a href="https://solaci.org/en/2015/06/01/what-is-a-catheterization/" title="Read more" >...</a>
Aortic valve stenosis occurs when calcium deposits in the valve cause leaflets hardening. It is a degenerative process that gets worse as the person ages. As the disease develops, valve opening is narrowed, obstructing blood flow and forcing the heart to pump harder. Aortic valve replacement is the standard treatment for severe aortic stenosis. Without<a href="https://solaci.org/en/2015/06/01/aortic-stenosis-patient-guide/" title="Read more" >...</a>
EDITORIAL Dr. Matías Sztejfman ARTICULO DE REVISION Dr. Fernando Cura Implante Valvular Aórtico en pacientes de alto riesgo quirúrgico, evidencia y hacia donde nos dirigimos REVISION BIBLIOGRAFICA Dr. Yigal Piña Reyna Estudio CoreValve US Pivotal en Pacientes de alto riesgo quirúrgico CASO CLINICO Dres. Gabriel Maluenda, Mario Araya y Michael Howard TAVI con Sapien XT™<a href="https://solaci.org/en/2015/05/19/educational-journal-n-100/" title="Read more" >...</a>
1. ESTUDIOS DE TECNOLOGIAS EN INTERVENCIONES CORONARIAS • RIBS IV – Presentador: Fernando Alfonso • ABSORB II – Presentador: Patrick Serruys 2. ESTUDIOS DE FARMACOLOGIA EN INTERVENCIONES CORONARIAS • ISAR-TRIPLE – Presentador: Nikolaus Sarafoff • SECURITY – Presentador: Antonio Colombo • BRIGHT – Presentador: Yalin Hang 3. ESTUDIOS EN IMÁGENES CORONARIAS • IVUS-CTO – Presentador:<a href="https://solaci.org/en/2015/05/19/educational-journal-n-98/" title="Read more" >...</a>
Original title: Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation. Reference: Manuel Martínez-Sellés et al. EuroIntervention 2015;10-online publish-ahead-of-print February 2015. Prosthesis endocarditis is a complication with serious clinical consequences due to its high morbimortality. Infective endocarditis (IE) in TAVI has been described in few cases and, in cohort studies, it occurs within 0 to<a href="https://solaci.org/en/2015/03/13/incidence-and-clinical-impact-of-post-tavi-infective-endocarditis/" title="Read more" >...</a>
Original title: Impact of chronic kidney disease on the outcome of transcatheter aortic valve implantation: results from the FRANCE 2 Registry. Reference: Atsushi Oguri, et al. EuroIntervention 2015;10:e1-9 Globally, 13% of patients present kidney failure, which has been associated to a worse evolution not only of TAVI outcomes but also of other cardiovascular intervention outcomes. Most studies, including<a href="https://solaci.org/en/2015/02/19/impact-of-kidney-function-on-tavi-outcome/" title="Read more" >...</a>